Risk-based treatment approaches for neuroblastoma have been ongoing for decades. However, the criteria used to define risk in various institutional and cooperative groups were disparate, limiting the ...

Please provide your email address to receive an email when new articles are posted on . Determining risk classifications of children with neuroblastoma is “paramount” to optimizing their care, the ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Patients With Biomarker-Selected ...

Saurin P1 lesions were linked with an increased risk for rebleeding in patients with suspected small bowel bleeding, when ...